MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

    A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To identify modifiable vascular risk factors (VRFs) associated with cognitive decline in early PD. Background: The importance of the early identification of modifiable risk…
  • 2019 International Congress

    Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.

    TZ. Ren, K. Nie, LJ. Wang (Guangzhou, China)

    Objective: The aim of this study was to compare the structure of gut microbiota and short-chain fatty acid(SCFAs) in PD with mild cognitive impairment (PD-MCI),…
  • 2019 International Congress

    Neuropsychological differences between patients with Parkinson’s Disease and Essential Tremor

    M. Zorn, K. Duff, J. Rolston, C. Aquino, J. Ballard, P. Moretti (Salt Lake City, UT, USA)

    Objective: Investigate neuropsychological differences between Parkinson's disease (PD) and essential tremor (ET) patients presenting for evaluation for Deep Brain Stimulation (DBS) surgery. Background: Although patients with PD and ET have…
  • 2019 International Congress

    Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease

    H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

    Objective: To study the neural connections between orbitofrontal cortex (OFC) and olfactory cortex and analyze their consistency ranging from control group to Parkinson’s Disease (PD)…
  • 2019 International Congress

    The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study

    H. Wilson, G. Dervenoulas, G. Pagano, A. Chandra, F. Niccolini, M. Esposito, R. Gunn, L. Ricciardi, E. Rabiner, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate the role of synaptic vesicle glycoprotein 2A (SV2A) in Parkinson’s disease dementia (PDD) and Dementia with Lewy bodies (DLB) using…
  • 2019 International Congress

    Reviewing the clinical and mutational spectrum of SLC20A2, PDGFB, PDGFRB, XPR1 and MYORG mutations in Primary Familial Brain Calcification (PFBC) for MDSGene

    A. Balck, S. Schaake, J. Margolesky, A. Domingo, C. Klein, A. Westenberger (Lubeck, Germany)

    Objective: We present the clinical and mutational spectrum of SLC20A2, PDGFB, PDGFRB, XPR1, and MYORG mutations, thereby adding a new gene, MYORG, recently found to…
  • 2019 International Congress

    Language disorders in Progressive Supranuclear Palsy: an underestimated condition?

    E. Del Prete, L. Tommasini, D. Frosini, S. Mazzucchi, C. Pagni, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: We aimed to investigate executive functions and languages abilities in PSP patients and in Progressive Supranuclear Palsy (PSP) subgroups [PSP-Richardson’s Syndrome (PSP-RS) and PSP-non-RS]…
  • 2019 International Congress

    The frequency and impact of mutations in the GBA gene and APOε4 polymorphisms on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

    T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, R. Shahar, T. Gurevich, A. Orr-Urtreger, N. Giladi, N. Bregman (Tel Aviv, Israel)

    Objective: We aimed to explore the frequency and clinical impact of GBA mutations and APOε4 polymorphisms in a cohort of Ashkenazi Jewish (AJ) patients with…
  • 2019 International Congress

    A Study of Social Cognition in Parkinson’s Disease

    S. Meenakshisundaram, LN. Ranganathan (Chennai, India)

    Objective: To study the social cognition in patients with PD and compare it with normal controls Background: Patients with PD have difficulty expressing emotion which…
  • 2019 International Congress

    Brain amyloid contribution to cognitive dysfunction in Lewy bodies disorders: a pilot study

    R. Biundo, E. Fiorenzato, D. Cecchin, C. Salvotti, L. Weis, A. Antonini (Venice, Italy)

    Objective: To investigate regional [18F]florbetapir binding to amyloid-β and its contribution to cognitive dysfunction in Lewy bodies disorders. Background: Lewy bodies disorders like Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley